Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.

We read with great interest the recently published American College of Rheumatology (ACR) guidance for the management of rheumatic disease in adult patients during the COVID-19 pandemic (1). We greatly appreciate this effort by the ACR which will help rheumatologists optimize management of rheumatic illnesses during the coronavirus disease 2019 (COVID-19) pandemic. We would like to make an important addition to this "living document", and hope this to be addressed in future updates as more data becomes available.